SCIENCE TO CONSUMERS INC

As of February 28, 2017, SCIENCE TO CONSUMERS INC carries a market capitalization of 3.51M, placing it among publicly traded companies globally. Its enterprise value stands at 3.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of February 28, 2017, SCIENCE TO CONSUMERS INC has 31.90M shares outstanding.

These figures are as of February 28, 2017.

As of February 28, 2017, SCIENCE TO CONSUMERS INC maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -52.24, indicating conservative leverage, while an interest coverage ratio of -20.10 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended February 28, 2017. Return on assets (ROA) is negative at -884.40, reflecting losses generated across the asset base.

As of the close on October 19, 2026, SCIENCE TO CONSUMERS INC's stock has gained approximately 100.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.02.

Over the twelve months ended February 28, 2017, SCIENCE TO CONSUMERS INC generated - - in revenue and converted that into -69,328.00 in net income, yielding earnings per share of 0.00. EBITDA reached -51,167.00, while operating income came in at -55,231.00.

As of February 28, 2017, SCIENCE TO CONSUMERS INC holds - - in cash and equivalents against 41,973.00 in total debt, resulting in a net debt position of 41,973.00. Total book value stands at -80,350.00, with working capital of -86,157.00 providing operational flexibility.

SCIENCE TO CONSUMERS INC produced -50,952.00 in operating cash flow over the twelve months ended February 28, 2017.

These figures cover the twelve months ended February 28, 2017. Free cash flow yield is negative at -1.45: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

SCIENCE TO CONSUMERS INC's most recent stock split took place on August 19, 2014 with a 1:7 split ratio.